These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33524944)

  • 1. Intraarterial delivery of virotherapy for glioblastoma.
    Srinivasan VM; Lang FF; Kan P
    Neurosurg Focus; 2021 Feb; 50(2):E7. PubMed ID: 33524944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic Zika Virus: New Option for Glioblastoma Treatment.
    Zhou C; Chen Q; Chen Y; Qin CF
    DNA Cell Biol; 2023 Jun; 42(6):267-273. PubMed ID: 36350682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma.
    Monie DD; Bhandarkar AR; Parney IF; Correia C; Sarkaria JN; Vile RG; Li H
    Neurosurg Focus; 2021 Feb; 50(2):E10. PubMed ID: 33524942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas.
    Stergiopoulos GM; Concilio SC; Galanis E
    Curr Treat Options Oncol; 2024 Jul; 25(7):952-991. PubMed ID: 38896326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages.
    Shen Z; Liu X; Fan G; Na J; Liu Q; Lin F; Zhang Z; Zhong L
    J Transl Med; 2023 Nov; 21(1):842. PubMed ID: 37993941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of the efficacy of viro-immunotherapy: A review.
    de Graaf JF; Huberts M; Fouchier RAM; van den Hoogen BG
    Cytokine Growth Factor Rev; 2020 Dec; 56():124-132. PubMed ID: 32919831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies.
    Shah S
    Med Sci (Basel); 2023 Dec; 12(1):. PubMed ID: 38249077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.
    Wei D; Xu J; Liu XY; Chen ZN; Bian H
    Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy.
    Volovat SR; Scripcariu DV; Vasilache IA; Stolniceanu CR; Volovat C; Augustin IG; Volovat CC; Ostafe MR; Andreea-Voichița SG; Bejusca-Vieriu T; Lungulescu CV; Sur D; Boboc D
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The two-faces of NK cells in oncolytic virotherapy.
    Marotel M; Hasim MS; Hagerman A; Ardolino M
    Cytokine Growth Factor Rev; 2020 Dec; 56():59-68. PubMed ID: 32586674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma.
    Keshavarz M; Dianat-Moghadam H; Ghorbanhosseini SS; Sarshari B
    Biochim Biophys Acta Gen Subj; 2024 Sep; 1868(9):130662. PubMed ID: 38901497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cell plasticity in glioblastoma multiforme: a perspective on future directions in oncolytic virotherapy.
    Kim DS
    Future Oncol; 2020 Oct; 16(28):2251-2264. PubMed ID: 32744059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic Viruses in Cancer Treatment: A Review.
    Lawler SE; Speranza MC; Cho CF; Chiocca EA
    JAMA Oncol; 2017 Jun; 3(6):841-849. PubMed ID: 27441411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy.
    Wang X; Shen Y; Wan X; Hu X; Cai WQ; Wu Z; Xin Q; Liu X; Gui J; Xin HY; Xin HW
    J Transl Med; 2023 Jul; 21(1):500. PubMed ID: 37491263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword.
    Blitz SE; Kappel AD; Gessler FA; Klinger NV; Arnaout O; Lu Y; Peruzzi PP; Smith TR; Chiocca EA; Friedman GK; Bernstock JD
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment.
    Feola S; Russo S; Ylösmäki E; Cerullo V
    Pharmacol Ther; 2022 Aug; 236():108103. PubMed ID: 34954301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment.
    Ghasemi Darestani N; Gilmanova AI; Al-Gazally ME; Zekiy AO; Ansari MJ; Zabibah RS; Jawad MA; Al-Shalah SAJ; Rizaev JA; Alnassar YS; Mohammed NM; Mustafa YF; Darvishi M; Akhavan-Sigari R
    Cell Commun Signal; 2023 Feb; 21(1):43. PubMed ID: 36829187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in oncolytic viruses modified with nanomaterials for intravenous application.
    Chen L; Ma Z; Xu C; Xie Y; Ouyang D; Song S; Zhao X; Liu F
    Cancer Biol Med; 2023 Nov; 20(11):830-55. PubMed ID: 38009779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.
    Hamad A; Yusubalieva GM; Baklaushev VP; Chumakov PM; Lipatova AV
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Viruses and Cancer Immunotherapy.
    Malhotra J; Kim ES
    Curr Oncol Rep; 2023 Jan; 25(1):19-28. PubMed ID: 36441447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.